Tonix Pharma's market cap is currently $191.49M. The company's EPS TTM is $-3.59; its P/E ratio is -0.02; Tonix Pharma is scheduled to report earnings on November 10, 2025, and the estimated EPS forecast is $-3.19. See an overview of income statement, balance sheet, and cash flow financials.
